Healthy Biotech, a subsidiary holding of Kindstar Globalgene Technology Inc., is CE certified for nine of its hematological malignancy diagnostic products, indicating that our products comply with the regulatory requirements of the European Union and can be sold in the EU as well as countries that recognize CE certification. The nine products are as follows:  

● Lymphoma Gene Mutation Detection Kit (RTS)

● Myeloid Tumor Gene Mutation Detection Kit (RTS)

● Clinical Exome Sequencing Detection Kit (RTS)

● T-cell Receptor Gene Rearrangements Clonality Assessment and Minimal Residual Disease Detection Kit (RTS)

● Immunoglobulin Gene Rearrangements Clonality Assessment and Minimal Residual Disease Detection Kit (RTS)

● BCR-ABL1 Fusion Gene Qualitative Detection Kit (PCR-fluorescence probing)

● PML-RARA Fusion Gene Qualitative Detection Kit (PCR-fluorescence probing)

● RUNX1-RUNX1TA Fusion Gene Qualitative Detection Kit (PCR-fluorescence probing)

● Human JAK2-V617F Mutation Detection Kit (PCR-fluorescence probing)

These nine kits can be used for clinical diagnosis, prognosis evaluation and targeted therapy of lymphoma, myeloid malignancies, myeloproliferative neoplasms (MPN), chronic myelocytic leukemia (CML), acute myeloid leukemia (AML), etc.